Acurx Announces New Microbiome Data from Its Phase 2a Clinical Trial of Ibezapolstat for CDI at the 9th International C. diff. Conference

November 1, 2021

Biotechnology

bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital

June 2, 2025
Coherus Completes Strategic Transformation to Coherus Oncology, Focusing Exclusively on Innovative Cancer Therapeutics

May 30, 2025
Silo Pharma Partners with Resyca for IND-Supporting Intranasal Drug-Device Study of PTSD Drug SPC-15

May 21, 2025
Rani Therapeutics Announces Research Agreement with Chugai

May 19, 2025